Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience
- PMID: 38988256
- PMCID: PMC11264298
- DOI: 10.1093/europace/euae192
Efficacy and safety of focal pulsed-field ablation for ventricular arrhythmias: two-centre experience
Abstract
Aims: A pulsed electric field (PF) energy source is a novel potential option for catheter ablation of ventricular arrhythmias (VAs) as it can create deeper lesions, particularly in scarred tissue. However, very limited data exist on its efficacy and safety. This prospective observational study reports the initial experience with VA ablation using focal PF.
Methods and results: The study population consisted of 44 patients (16 women, aged 61 ± 14years) with either frequent ventricular premature complexes (VPCs, 48%) or scar-related ventricular tachycardia (VT, 52%). Ablation was performed using an irrigated 4 mm tip catheter and a commercially available PF generator. On average, 16 ± 15 PF applications (25 A) were delivered per patient. Acute success was achieved in 84% of patients as assessed by elimination of VPC or reaching non-inducibility of VT. In three cases (7%), a transient conduction system block was observed during PF applications remotely from the septum. Root analysis revealed that this event was caused by current leakage from the proximal shaft electrodes in contact with the basal interventricular septum. Acute elimination of VPC was achieved in 81% patients and non-inducibility of VT in 83% patients. At the 3-month follow-up, persistent suppression of the VPC was confirmed on Holter monitoring in 81% patients. In the VT group, the mean follow-up was 116 ± 75 days and a total of 52% patients remained free of any VA.
Conclusion: Pulsed electric field catheter ablation of a broad spectrum of VA is feasible with acute high efficacy; however, the short-term follow-up is less satisfactory for patients with scar-related VT.
Keywords: Catheter ablation; Pulsed-field energy; Ventricular premature complexes; Ventricular tachycardia.
© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: P.P. reports personal fees from Biotronik, Biosense Webster, Boston Scientific, Medtronic, and St. Jude Medical (Abbott). A.B. reports personal fees from Biotronik for participation in the scientific advisory board and has received speaker honoraria from Biotronik, Boston Scientific, and St. Jude Medical (Abbott). J.K. reports personal fees from Biosense Webster, Boston Scientific, GE Healthcare, Medtronic, and St. Jude Medical (Abbott) for participation in scientific advisory boards and has received speaker honoraria from Biosense Webster, Biotronik, Boston Scientific, Medtronic, and St. Jude Medical (Abbott). The remaining authors have no disclosures.
Figures
References
-
- Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997–4126. - PubMed
-
- Ravi V, Poudyal A, Khanal S, Khalil C, Vij A, Sanders D et al. A systematic review and meta-analysis comparing radiofrequency catheter ablation with medical therapy for ventricular tachycardia in patients with ischemic and non-ischemic cardiomyopathies. J Interv Card Electrophysiol 2023;66:161–75. - PubMed
-
- Della Bella P, Baratto F, Vergara P, Bertocchi P, Santamaria M, Notarstefano P et al. Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation 2022;145:1829–38. - PubMed
-
- Leshem E, Zilberman I, Barkagan M, Shapira-Daniels A, Sroubek J, Govari A et al. Temperature-controlled radiofrequency ablation using irrigated catheters: maximizing ventricular lesion dimensions while reducing steam-pop formation. JACC Clin Electrophysiol 2020;6:83–93. - PubMed
-
- Younis A, Buck E, Santangeli P, Tabaja C, Garrott K, Lehn L et al. Efficacy of pulsed field vs radiofrequency for the reablation of chronic radiofrequency ablation substrate: redo pulsed field ablation. JACC Clin Electrophysiol 2024;10:222–34. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
